Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered (Q34108906)

31 July 2017

1 reference

title

Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered (English)

1 reference

31 July 2017

1 reference

Ian Hindmarch

1

1 reference

31 July 2017

Kenji Hashimoto

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 April 2010

1 reference

31 July 2017

published in

Human Psychopharmacology

1 reference

31 July 2017

volume

25

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

193-200

1 reference

Hippocampal volume reduction in major depression.

31 July 2017

cites work

1 reference

A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness

21 January 2018

1 reference

JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites

21 January 2018

1 reference

A review of the neuropsychological effects of commonly used prescription medications

21 January 2018

1 reference

Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.

21 January 2018

1 reference

7 January 2021

Does stress damage the brain?

1 reference

7 January 2021

Perceived stress and cognitive vulnerability mediate the effects of personality disorder comorbidity on treatment outcome in major depressive disorder: a path analysis study

1 reference

7 January 2021

Reflection, brooding, and suicidality: a preliminary study of different types of rumination in individuals with a history of major depression.

1 reference

7 January 2021

Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders

1 reference

7 January 2021

Comorbid anxiety disorder in late life depression: association with memory decline over four years

1 reference

7 January 2021

Is hippocampal atrophy a future drug target?

1 reference

7 January 2021

Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.

1 reference

7 January 2021

Neurocognitive profiles in elderly patients with frontotemporal degeneration or major depressive disorder

1 reference

7 January 2021

Pharmacological approaches to the treatment of residual symptoms

1 reference

7 January 2021

Enlargement of the amygdala in patients with a first episode of major depression.

1 reference

7 January 2021

1 reference

7 January 2021

Sigma receptors: biology and therapeutic potential

1 reference

7 January 2021

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

1 reference

7 January 2021

Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders

1 reference

7 January 2021

Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival

1 reference

7 January 2021

An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand

1 reference

7 January 2021

The behavioural toxicity of the selective serotonin reuptake inhibitors

1 reference

7 January 2021

High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503.

1 reference

7 January 2021

Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia

1 reference

7 January 2021

99mTc-labeled sigma-receptor-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells.

1 reference

7 January 2021

Effects of sigma receptor ligands on conditioned fear stress.

1 reference

7 January 2021

Course of illness, hippocampal function, and hippocampal volume in major depression

1 reference

7 January 2021

Neurobiology of depression: an integrated view of key findings

1 reference

7 January 2021

Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice

1 reference

7 January 2021

Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis

1 reference

7 January 2021

Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands

1 reference

7 January 2021

The attenuation of learning impairments induced after exposure to CO or trimethyltin in mice by sigma (sigma) receptor ligands involves both sigma1 and sigma2 sites

1 reference

7 January 2021

Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities

1 reference

7 January 2021

The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunities

1 reference

7 January 2021

Mood disorders and allostatic load

1 reference

7 January 2021

Quantitative MRI of the hippocampus and amygdala in severe depression

1 reference

7 January 2021

Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance

1 reference

7 January 2021

Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain

1 reference

7 January 2021

Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways

1 reference

7 January 2021

Strain differences in sigma(1) receptor-mediated behaviours are related to neurosteroid levels

1 reference

7 January 2021

Neurocognitive impairment in drug-free patients with major depressive disorder.

1 reference

7 January 2021

The As and Ds of stress: metabolic, morphological and behavioral consequences

1 reference

7 January 2021

A placebo controlled investigation into the effects of paroxetine and mirtazapine on measures related to car driving performance.

1 reference

7 January 2021

Depression, antidepressants, and the shrinking hippocampus

1 reference

7 January 2021

Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors

1 reference

7 January 2021

Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats.

1 reference

7 January 2021

A natural history of the human mind: tracing evolutionary changes in brain and cognition

1 reference

7 January 2021

Treatment and recovery rate in depression: a critical analysis

1 reference

7 January 2021

Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients

1 reference

7 January 2021

Antidepressant treatment of psychotic major depression: potential role of the sigma receptor

1 reference

7 January 2021

The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition?

1 reference

7 January 2021

Hippocampal volume in geriatric depression

1 reference

7 January 2021

Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction

1 reference

7 January 2021

Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants

1 reference

7 January 2021

Antidepressants and the risk of falls among nursing home residents

1 reference

7 January 2021

2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives: novel, potent and selective sigma1 receptor ligands.

1 reference

7 January 2021

The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization.

1 reference

7 January 2021

Clinical trials with sigma ligands

1 reference

7 January 2021

Childhood trauma associated with smaller hippocampal volume in women with major depression.

1 reference

7 January 2021

Psychotropic medication use and accidents, injuries and cognitive failures.

1 reference

7 January 2021

Anti-amnesic effect of dimemorfan in mice

1 reference

7 January 2021

Halogenated 4-(phenoxymethyl)piperidines as potential radiolabeled probes for sigma-1 receptors: in vivo evaluation of [123I]-1-(iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]pip eri dine.

1 reference

7 January 2021

Psychomotor retardation: clinical, theoretical, and psychometric aspects

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1106

1 reference

release_wvvx2lcx3fcstadkqx7hzvivqm

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wvvx2lcx3fcstadkqx7hzvivqm

24 November 2022

mapped directly with Wikidata item

1 reference